Table 2.
Clinical and hematologic characteristics of seropositive children attending ART care in Benishangul Gumuz public health facility from 2009 up to 2020.
| Variables | Categories | No. | Frequency |
|---|---|---|---|
| Dietary counseling during follow-up | Yes | 465 | 64.5 |
| No | 256 | 35.51 | |
| Admission history of SAM | Yes | 124 | 17.35 |
| No | 597 | 82.6 | |
| Opportunistic infection (OIs at baseline) | Yes | 258 | 35.8 |
| No | 453 | 64.2 | |
| Types of ART regiment | D4t-3TC-NVP | 48 | 6.66 |
| D4t-3TC-EFV | 26 | 3.6 | |
| AZT-3TC-NVP | 293 | 40.6 | |
| AZT-3TC-EFV | 165 | 22.8 | |
| TDF-3TC-EFV | 104 | 14.43 | |
| AZT-3TC-LPV/R | 36 | 4.99 | |
| ABC-3TC-NVP | 25 | 3.5 | |
| ABC-3TC-EFV | 24 | 3.3 | |
| ART regimen change | Yes | 211 | 29.3 |
| No | 510 | 70.74 | |
| Functional status (age ⩽5 years) | Appropriate | 69 | 71.98 |
| Delay | 15 | 15.63 | |
| Regression | 12 | 12.5 | |
| Developmental history (age >5 years) | Working | 488 | 77.96 |
| Ambulatory | 87 | 13.90 | |
| Bedridden | 51 | 8.15 | |
| Adherence | Good | 356 | 49.4 |
| Fair | 177 | 24.55 | |
| Poor | 188 | 26.1 | |
| WHO clinical stage | I | 237 | 32.87 |
| II | 202 | 28.1 | |
| III | 170 | 23.6 | |
| IV | 112 | 15.5 | |
| IPT | Yes | 451 | 62.5 |
| No | 270 | 37.45 | |
| CPT | Yes | 419 | 58.1 |
| No | 302 | 41.9 | |
| CD4 count or percent | Below the threshold | 308 | 42.7 |
| Above threshold | 413 | 57.3 | |
| Hemoglobin level (g dL−1) | ⩽10 | 229 | 31.78 |
| >10 | 492 | 68.24 | |
| ART eligibility criteria | Immunologic | 81 | 11.3 |
| Clinical stage | 96 | 13.3 | |
| WHO clinical stage | 79 | 10.96 | |
| By CD4 threshold | 199 | 27.60 | |
| Testing and treat | 266 | 36.89 | |
| Types of opportunistic other than TB | Bacterial pneumonia | 79 | 30.6 |
| Diarrhea | 74 | 28.8 | |
| Meningitis | 9 | 3.6 | |
| PCP | 6 | 2.33 | |
| Skin dermatitis | 7 | 2.7 | |
| Kaposi’s sarcoma | 5 | 1.9 | |
| Acute/chronic otitis media | 9 | 3.5 | |
| Others | 3 | 1.18 | |
| TB | 66 | 9.15 | |
| Duration on ART (months) | ⩽36 | 223 | 30.93 |
| 36–72 | 295 | 40.92 | |
| ⩾72 | 203 | 28.16 | |
| Current status of children | On follow-up | 539 | 74.76 |
| Transferred into the adult cohort | 68 | 9.43 | |
| Lost from follow-up | 13 | 1.8 | |
| Drop | 11 | 1.53 | |
| Died | 90 | 12.48 | |
| Maternal PMTC follow-up history | Yes | 487 | 67.6 |
| No | 234 | 32.4 | |
| MUSIC (CM) | ⩽11.5 | 270 | 37.45 |
| >11.5 | 451 | 62.55 | |
| Tuberculosis treatment history | Yes | 66 | 9.15 |
| No | 655 | 90.85 | |
| Underweight (WFA) | Normal | 491 | 68.1 |
| WAZ < −2 | 144 | 19.9 | |
| WAZ < −3 | 86 | 11.93 | |
| Stunting (HFA) | Normal | 428 | 59.4 |
| HAZ < −2 | 154 | 21.4 | |
| HAZ < −3 | 139 | 19.2 | |
| Wasting (WFH) | Normal | 531 | 73.5 |
| WHZ < BAZ−2 | 119 | 16.6 | |
| WHZ or BAZ < −3 | 71 | 9.9 | |
| Underweight (WFA) | Normal | 491 | 68.1 |
| WAZ < −2 | 144 | 19.9 | |
| WAZ < −3 | 86 | 11.93 | |
| Survival status of children | Died | 90 | 12.07 |
| Survived | 634 | 87.93 |
SAM: severe acute malnutrition; ART: antiretroviral therapy; WHO: World Health Organization; WFA: weight for age; WFH: weight for height; HAZ: height for age Z-score; WAZ: weight for age Z-score; WHZ: weight for height Z-score; WHO: World Health Organization.